Ovarian cancer is the deadliest gynecological malignancy due to its symptomless early stage, metastasis, and high recurrence rate. The tumor microenvironment contributes to the ovarian cancer progression, metastasis, and chemoresistance. Adipose-derived stem cell in the tumor microenvironment of ovarian cancer, as a key player, interacts with ovarian cancer cells to form the cancer-associated fibroblasts and cancer-associated adipocytes, and secretes soluble factors to activate tumor cell signaling, which can promote ovarian cancer metastasis and chemoresistance. We summarize in this review the recent progress in the studies of interactions between adipose-derived stem cell and ovarian cancer, thus, to provide some insight for ovarian cancer therapy through targeting adipose-derived stem cell.
NashZMenonU.Ovarian cancer screening: current status and future directions. Best Pract Res Clin Obstet Gynaecol2020;
65:32–45
2.
ColomboNPeiretti M, Parma G, Lapresa M, Mancari R, Carinelli S, Sessa C, Castiglione M.
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol2010;
21:v23–30
3.
JiangYWangCZhouS.Targeting tumor microenvironment in ovarian cancer: premise and promise. Biochim Biophys Acta Rev Cancer2020;
1873:188361
4.
AnsellSMVonderheideRH.Cellular composition of the tumor microenvironment. Am Soc Clin Oncol Educ Book2013;DOI: 10.1200/EdBook_AM.2013.33.e91
5.
QuailDFJoyceJA.Microenvironmental regulation of tumor progression and metastasis. Nat Med2013;
19:1423–37
6.
LuoZWang Q, Lau WB, Lau B, Xu L, Zhao L, Yang H, Feng M, Xuan Y, Yang Y, Lei L, Wang C, Yi T, Zhao X, Wei Y, Zhou S.
Tumor microenvironment: the culprit for ovarian cancer metastasis?Cancer Lett2016;
377:174–82
7.
WhitesideTL.Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment. Semin Immunol2018;
35:69–79
8.
AtiyaHFrisbieLPressimoneCCoffmanL.Mesenchymal stem cells in the tumor microenvironment. Adv Exp Med Biol2020;
1234:31–42
9.
AlbarenqueSMZwackaRMMohrA.Both human and mouse mesenchymal stem cells promote breast cancer metastasis. Stem Cell Res2011;
7:163–71
10.
ShinagawaKKitadai Y, Tanaka M, Sumida T, Kodama M, Higashi Y, Tanaka S, Yasui W, Chayama K.
Mesenchymal stem cells enhance growth and metastasis of Colon cancer. Int J Cancer2010;
127:2323–33
11.
LiuTZhu K, Ke C, Yang S, Yang F, Li Z, Zhang Z.
Mesenchymal stem cells inhibited development of lung cancer induced by chemical carcinogens in a rat model. Am J Transl Res2017;
9:2891–900
12.
YulyanaYHo IA, Sia KC, Newman JP, Toh XY, Endaya BB, Chan JK, Gnecchi M, Huynh H, Chung AY, Lim KH, Leong HS, Iyer NG, Hui KM, Lam PY.
Paracrine factors of human fetal MSCs inhibit liver cancer growth through reduced activation of IGF-1R/PI3K/akt signaling. Mol Ther2015;
23:746–56
13.
OhlundDElyadaETuvesonD.Fibroblast heterogeneity in the cancer wound. J Exp Med2014;
211:1503–23
14.
Barcellos-de-SouzaPComito G, Pons-Segura C, Taddei ML, Gori V, Becherucci V, Bambi F, Margheri F, Laurenzana A, Del Rosso M, Chiarugi P.
Mesenchymal stem cells are recruited and activated into carcinoma-associated fibroblasts by prostate cancer microenvironment-derived TGF-beta1. Stem Cells2016;
34:2536–47
15.
ShangguanLTi X, Krause U, Hai B, Zhao Y, Yang Z, Liu F.
Inhibition of TGF-beta/smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects. Stem Cells2012;
30:2810–9
16.
ZhuWHuang L, Li Y, Zhang X, Gu J, Yan Y, Xu X, Wang M, Qian H, Xu W.
Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett2012;
315:28–37
17.
RodiniCOGoncalves da SilvaPBAssoniAFCarvalhoVMOkamotoOK.Mesenchymal stem cells enhance tumorigenic properties of human glioblastoma through independent cell-cell communication mechanisms. Oncotarget2018;
9:24766–77
18.
KarnoubAEDash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA.
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature2007;
449:557–63
19.
MaffeyAStorini C, Diceglie C, Martelli C, Sironi L, Calzarossa C, Tonna N, Lovchik R, Delamarche E, Ottobrini L, Bianco F.
Mesenchymal stem cells from tumor microenvironment favour breast cancer stem cell proliferation, cancerogenic and metastatic potential, via ionotropic purinergic signalling. Sci Rep2017;
7:13162
20.
NishimuraKSembaSAoyagiKSasakiHYokozakiH.Mesenchymal stem cells provide an advantageous tumor microenvironment for the restoration of cancer stem cells. Pathobiology2012;
79:290–306
21.
OhlssonLBVarasLKjellmanCEdvardsenKLindvallM.Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix. Exp Mol Pathol2003;
75:248–55
22.
LuYRYuan Y, Wang XJ, Wei LL, Chen YN, Cong C, Li SF, Long D, Tan WD, Mao YQ, Zhang J, Li YP, Cheng JQ.
The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo. Cancer Biol Ther2008;
7:245–51
23.
LengyelE.Ovarian cancer development and metastasis. Am J Pathol2010;
177:1053–64
24.
MuehlbergFLSong YH, Krohn A, Pinilla SP, Droll LH, Leng X, Seidensticker M, Ricke J, Altman AM, Devarajan E, Liu W, Arlinghaus RB, Alt EU.
Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis2009;
30:589–97
25.
JiSQCao J, Zhang QY, Li YY, Yan YQ, Yu FX.
Adipose tissue-derived stem cells promote pancreatic cancer cell proliferation and invasion. Braz J Med Biol Res2013;
46:758–64
KloppAHZhang Y, Solley T, Amaya-Manzanares F, Marini F, Andreeff M, Debeb B, Woodward W, Schmandt R, Broaddus R, Lu K, Kolonin MG.
Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors. Clin Cancer Res2012;
18:771–82
28.
ZhangYDaquinag A, Traktuev DO, Amaya-Manzanares F, Simmons PJ, March KL, Pasqualini R, Arap W, Kolonin MG.
White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res2009;
69:5259–66
29.
HeoSCHeo SC, Lee KO, Shin SH, Kwon YW, Kim YM, Lee CH, Kim YD, Lee MK, Yoon MS, Kim JH.
Periostin mediates human adipose tissue-derived mesenchymal stem cell-stimulated tumor growth in a xenograft lung adenocarcinoma model. Biochim Biophys Acta2011;
1813:2061–70
30.
LiWXuHQianC.c-Kit-positive adipose tissue-derived mesenchymal stem cells promote the growth and angiogenesis of breast cancer. Biomed Res Int2017;
2017:7407168
31.
SalhaSGehmert S, Brebant V, Anker A, Loibl M, Prantl L, Gehmert S.
PDGF regulated migration of mesenchymal stem cells towards malignancy acts via the PI3K signaling pathway. Clin Hemorheol Microcirc2018;
70:543–51
32.
NowickaAMarini FC, Solley TN, Elizondo PB, Zhang Y, Sharp HJ, Broaddus R, Kolonin M, Mok SC, Thompson MS, Woodward WA, Lu K, Salimian B, Nagrath D, Klopp AH.
Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance. PloS One2013;
8:e81859
33.
ChuYTang H, Guo Y, Guo J, Huang B, Fang F, Cai J, Wang Z.
Adipose-derived mesenchymal stem cells promote cell proliferation and invasion of epithelial ovarian cancer. Exp Cell Res2015;
337:16–27
34.
HassROtteA.Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment. Cell Commun Signal2012;
10:26
35.
ChuYYou M, Zhang J, Gao G, Han R, Luo W, Liu T, Zuo J, Wang F.
Adipose-derived mesenchymal stem cells enhance ovarian cancer growth and metastasis by increasing thymosin beta 4X-linked expression. Stem Cells Int2019;
2019:9037197
36.
ChuYWang Y, Li K, Liu M, Zhang Y, Li Y, Hu X, Liu C, Zhou H, Zuo J, Peng W.
Human omental adipose-derived mesenchymal stem cells enhance autophagy in ovarian carcinoma cells through the STAT3 signalling pathway. Cell Signal2020;
69:109549
37.
ChoJAPark H, Lim EH, Kim KH, Choi JS, Lee JH, Shin JW, Lee KW.
Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts. Gynecol Oncol2011;
123:379–86
38.
ChoJAParkHLimEHLeeKW.Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells. Int J Oncol2012;
40:130–8
39.
ZhangYTang H, Cai J, Zhang T, Guo J, Feng D, Wang Z.
Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion. Cancer Lett2011;
303:47–55
40.
SpaethELDembinski JL, Sasser AK, Watson K, Klopp A, Hall B, Andreeff M, Marini F.
Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PloS One2009;
4:e4992
41.
SchauerIGSoodAKMokSLiuJ.Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer. Neoplasia2011;
13:393–405
42.
NiemanKMKenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, Yamada SD, Peter ME, Gwin K, Lengyel E.
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med2011;
17:1498–503
43.
CoffmanLGChoi YJ, McLean K, Allen BL, di Magliano MP, Buckanovich RJ.
Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop. Oncotarget2016;
7:6916–32
44.
WenYGuoYHuangZCaiJWangZ.Adipose‑derived mesenchymal stem cells attenuate cisplatin‑induced apoptosis in epithelial ovarian cancer cells. Mol Med Rep2017;
16:9587–92
45.
SookramJZheng A, Linden KM, Morgan AB, Brown SA, Ostrovsky O.
Epigenetic therapy can inhibit growth of ovarian cancer cells and reverse chemoresistant properties acquired from metastatic omentum. Int J Gynecol Obstet2019;
145:225–32
46.
KhalilCMoussa M, Azar A, Tawk J, Habbouche J, Salameh R, Ibrahim A, Alaaeddine N.
Anti-proliferative effects of mesenchymal stem cells (MSCs) derived from multiple sources on ovarian cancer cell lines: an in-vitro experimental study. J Ovarian Res2019;
12:70
47.
RezaAChoiYJYasudaHKimJH.Human adipose mesenchymal stem cell-derived exosomal-miRNAs are critical factors for inducing anti-proliferation signalling to A2780 and SKOV-3 ovarian cancer cells. Sci Rep2016;
6:38498
48.
PinillaSAlt E, Abdul Khalek FJ, Jotzu C, Muehlberg F, Beckmann C, Song YH.
Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Lett2009;
284:80–5
49.
WeigandABoos AM, Tasbihi K, Beier JP, Dalton PD, Schrauder M, Horch RE, Beckmann MW, Strissel PL, Strick R.
Selective isolation and characterization of primary cells from normal breast and tumors reveal plasticity of adipose derived stem cells. Breast Cancer Res2016;
18:32
50.
McLeanKGong Y, Choi Y, Deng N, Yang K, Bai S, Cabrera L, Keller E, McCauley L, Cho KR, Buckanovich RJ.
Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J Clin Invest2011;
121:3206–19
51.
CoffmanLGPearson AT, Frisbie LG, Freeman Z, Christie E, Bowtell DD, Buckanovich RJ.
Ovarian carcinoma-associated mesenchymal stem cells arise from tissue-specific normal stroma. Stem Cells2019;
37:257–69
52.
MalekshahOMSarkar S, Nomani A, Patel N, Javidian P, Goedken M, Polunas M, Louro P, Hatefi A.
Bioengineered adipose-derived stem cells for targeted enzyme-prodrug therapy of ovarian cancer intraperitoneal metastasis. J Control Release2019;
311-312:273–87
